Clindamycin-resistant group B Streptococcus and failure of intrapartum prophylaxis to prevent early-onset disease

Autor:	Laurie S. Pulver, E. Kent Korgenski, Judy A. Daly, Lucy A. Savitz, Anne J. Blaschke, Carrie L. Byington
Rok vydání:	2009
Předmět:	musculoskeletal diseases Male medicine.medical_specialty medicine.drug_class Antibiotics Microbial Sensitivity Tests medicine.disease_cause Group B Article Streptococcus agalactiae Pregnancy Internal medicine Streptococcal Infections Drug Resistance Bacterial medicine Humans Antibiotic prophylaxis Pregnancy Complications Infectious reproductive and urinary physiology Antibacterial agent biology business.industry Streptococcus Clindamycin Infant Newborn Antibiotic Prophylaxis Streptococcaceae biology.organism_classification bacterial infections and mycoses Infectious Disease Transmission Vertical body regions Pediatrics Perinatology and Child Health Immunology Female Age of onset biological phenomena cell phenomena and immunity business medicine.drug
Zdroj:	The Journal of pediatrics. 156(3)
ISSN:	1097-6833
Popis:	Guidelines recommend intrapartum antibiotic prophylaxis (IAP) for parturient women who have a screen positive for group B Streptococcus (GBS). Clindamycin should be used for IAP only if the maternal GBS isolate is susceptible. We report a case of clindamycin-resistant GBS disease in a newborn infant whose mother received clindamycin IAP, and we review clindamycin susceptibility testing.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88e776827b203abec5e9a25186df730f https://pubmed.ncbi.nlm.nih.gov/20056242 Zobrazit plný text záznamu Full Text from ScienceDirect